首页> 美国卫生研究院文献>OncoTargets and therapy >Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines MIP-3α MIP-1β and IP-10
【2h】

Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines MIP-3α MIP-1β and IP-10

机译:MIP-3αMIP-1β和IP-10三种趋化因子促进舌鳞状细胞癌增殖和迁移的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this work was to investigate the role of chemokines in proliferation and migration of tongue squamous cell carcinoma (TSCC). Out of the 80 cytokines surveyed by a human cytokine antibody array, three chemokines, macrophage inflammatory protein-3α (MIP-3α), macrophage inflammatory protein-1β (MIP-1β), and interferon gamma-induced protein 10 (IP-10), showed elevated expression in TSCC cells (CAL-27 and UM-1), compared to the oral mucosal epithelial cells. Immunohistochemistry confirmed the high level of expression of MIP-3α in the TSCC tissues, especially in the high clinical stages. Furthermore, Western blot and immunofluorescence staining indicated that C-C chemokine receptor type 5, C-C chemokine receptor type 6, and C-X-C motif chemokine receptor 3, which are the receptors for MIP-3α, MIP-1β, and IP-10, respectively, were expressed in the TSCC cells. Viability assay showed MIP-3α, MIP-1β, and IP-10 led to the proliferation of the CAL-27 cells. Interestingly, MIP-1β and IP-10 also induced apoptosis in the TSCC cells. Transwell invasion assay showed MIP-3α and IP-10 could increase the invasive capability of TSCC cells; consistently, the enzymatic activities of matrix metalloproteinase-2 and matrix metalloproteinase-9 increased in the MIP-3α- and IP-10-treated cells. In summary, our results indicate the expression of MIP-3α, MIP-1β, and IP-10 increased in the TSCC cells. The elevated expression of MIP-3α and IP-10 promoted proliferation and migration of TSCC. These chemokines, along with their receptors, could be potential biomarkers and therapeutic targets for TSCC, especially for those in the high clinical stages.
机译:这项工作的目的是调查趋化因子在舌鳞状细胞癌(TSCC)增殖和迁移中的作用。在人类细胞因子抗体阵列调查的80种细胞因子中,三种趋化因子,巨噬细胞炎性蛋白3α(MIP-3α),巨噬细胞炎性蛋白1β(MIP-1β)和干扰素γ诱导蛋白10(IP-10)与口腔粘膜上皮细胞相比,TGF-β1在TSCC细胞(CAL-27和UM-1)中表达升高。免疫组织化学证实TSIP组织中MIP-3α的表达水平很高,尤其是在高临床阶段。此外,Western印迹和免疫荧光染色表明分别表达了MIP-3α,MIP-1β和IP-10的受体CC趋化因子受体5,CC趋化因子受体6和CXC基序趋化因子受体3。在TSCC细胞中。生存力测定显示MIP-3α,MIP-1β和IP-10导致CAL-27细胞增殖。有趣的是,MIP-1β和IP-10也诱导TSCC细胞凋亡。 Transwell侵袭实验表明,MIP-3α和IP-10可以提高TSCC细胞的侵袭能力。一致地,在MIP-3α和IP-10-处理的细胞中,基质金属蛋白酶2和基质金属蛋白酶9的酶活性增加。总之,我们的结果表明TSCC细胞中MIP-3α,MIP-1β和IP-10的表达增加。 MIP-3α和IP-10的高表达促进了TSCC的增殖和迁移。这些趋化因子及其受体可能是TSCC的潜在生物标志物和治疗靶标,尤其是对于处于高临床阶段的趋化因子而言。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号